Skip to main content
VREX
NASDAQ Manufacturing

Varex Imaging Reports Q2 Net Loss and Negative Cash Flow Amidst Debt Refinancing Costs

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$11.293
Mkt Cap
$495.677M
52W Low
$6.76
52W High
$14.565
52W Position info
67% above low
Off High info
22% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

VREX sits 67% above its 52-week low of $6.76 on elevated volume (1.8× avg).

Summary

Varex Imaging Corporation reported a net loss of $8.1 million and negative operating cash flow for Q2 FY26, primarily driven by a $9.2 million loss from debt extinguishment related to a new $490 million credit facility.


Key Events · Earnings and Guidance · VREX

  • Significant Net Loss Reported

    Varex Imaging reported a net loss of $8.1 million ($0.19 per share) for the second quarter of fiscal year 2026, a notable decline from a net income of $6.9 million ($0.17 per share) in the same period last year.

  • Negative Operating Cash Flow

    The company experienced a net cash outflow of $17.6 million from operating activities for the first six months of fiscal year 2026, reversing from a $26.1 million inflow in the prior year period.

  • Debt Refinancing with One-Time Loss

    A new $490 million credit facility was secured on March 13, 2026, used to repay $368 million in senior secured notes. This transaction resulted in a $9.2 million loss on debt extinguishment, contributing to the quarterly loss, but is projected to reduce annual interest expense by over $7 million.

  • Decreased Cash Position

    Cash and cash equivalents declined significantly to $85.3 million as of April 3, 2026, from $145.0 million at the beginning of the fiscal year.


Analysis · VREX · Manufacturing

Varex Imaging Corporation's second-quarter results reveal a significant financial downturn, marked by a net loss and negative operating cash flow. While the company successfully refinanced its debt with a new $490 million credit facility, this transaction incurred a substantial one-time loss of $9.2 million from debt extinguishment, directly impacting the quarter's profitability. The decline in cash and cash equivalents further highlights liquidity pressures. Although the refinancing is expected to yield future interest savings, investors should closely monitor the company's ability to return to positive operating cash flow and realize these anticipated benefits amidst ongoing global trade uncertainties.

At the time of this filing, VREX was trading at $11.29 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $495.7M. The 52-week trading range was $6.76 to $14.57. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VREX - Latest Insights

VREX
May 07, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.03
Real-time Price: $10.94 info
Change: -$0.095 (-0.86%) info
Market Cap: $460.363M info
VREX
May 07, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $11.83
Real-time Price: $10.94 info
Change: -$0.895 (-8%) info
Market Cap: $460.363M info
VREX
Mar 16, 2026, 8:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.14
Real-time Price: $10.94 info
Change: -$0.205 (-2%) info
Market Cap: $460.363M info
VREX
Feb 10, 2026, 4:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.08
Real-time Price: $10.94 info
Change: -$3.14 (-22%) info
Market Cap: $460.363M info
VREX
Feb 10, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.08
Real-time Price: $10.94 info
Change: -$3.14 (-22%) info
Market Cap: $460.363M info